Clinical Trial Update: Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer [Phase 1]

View source ↗

Summary

This is a Phase 1 safety trial evaluating the combination of nelfinavir, cisplatin, and pelvic radiation therapy for cervical cancer, with the study status note…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Nelfinavir (nelfinavir)

Snippet

Sponsor: University of Miami | Conditions: Cervical Cancer | Phase 1 | Status: COMPLETED